Browse by Poster Presenter

Skip to main content

ASCPT 2024 Annual Meeting Main banner

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

D
Damian, Valeriu

GSK
PII-222 - VALIDATION OF A QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL FOR CHRONIC HEPATITIS B.
Valeriu Damian
Favorite
Das, Sharmila

Bristol Meyers Squibb
PII-057 - INTEGRATED PHARMACOKINETIC (PK)/PHARMACODYNAMIC MODELING OF PK, SAFETY, AND EFFICACY DATA TO SUPPORT DOSE OPTIMIZATION OF BMS-986158, A BROMODOMAIN AND EXTRA-TERMINAL INHIBITOR (BETI), IN PATIENTS (PTS) WITH MYELOFIBROSIS (MF).
Sharmila Das
Favorite
Demin Jr, Oleg

InSysBio CY
PII-055 - EVALUATION OF VARIOUS STRATEGIES TO UNLEASH DNAM1 SIGNALING AND BLOCK TIGIT/PVRIG AXIS.
Oleg Demin Jr
Favorite
PII-213 - APPLICATION OF MECHANISTIC TRANSLATIONAL PK/RO/PA MODELING TO PREDICT FIRST-IN-HUMAN DOSE FOR HPN536, A T-CELL ENGAGER TARGETING MESOTHELIN.
Oleg Demin Jr
Favorite
Denney, William

Human Predictions
LB-016 - IMPROVED NONCOMPARTMENTAL HALF-LIFE ESTIMATION WITH TOBIT REGRESSION.
William Denney
Favorite
Der, Kenneth

Amgen
PII-093 - A PHASE 1, OPEN-LABEL STUDY TO EVALUATE THE PHARMACOKINETICS OF A SINGLE DOSE OF DAZODALIBEP IN HEALTHY JAPANESE AND CAUCASIAN PARTICIPANTS.
Kenneth Der
Favorite
Desai, Devam

Center of Pharmacometrics and Systems Pharmacology, University of Florida
PII-219 - QUANTITATIVE CHARACTERIZATION OF ENHANCED TISSUE DISTRIBUTION AND INNATE KILLING POTENTIAL OF UN-ENGINEERED GAMMA DELTA Ɣδ T CELLS USING A MECHANISTIC MODEL
Devam Desai
Favorite
Desta, Zeruesenay

Indiana University School of Medicine
PII-090 - A PHARMACOKINETIC AND ENZYME TURNOVER MODEL PREDICTS MAJOR ROLES FOR CYP2B6 GENOTYPES ON THE MAGNITUDE OF EFAVIREZ AUTOINDUCTION OF METABOLISM AND CLEARNCE IN HEALTHY VOLUNTEERS
Zeruesenay Desta
Favorite
Devineni, Damayanthi

Johnson & Johnson Innovative Medicine
PII-097 - AN INTEGRATED ASSESSMENT OF THE AME PROPERTIES OF SELTOREXANT UTILIZING PRECLINICAL IN VITRO, IN VIVO, AND HUMAN ADME DATA.
Damayanthi Devineni
Favorite
Dilizia, Michele

Recce Pharmaceuticals Ltd
PII-037 - FIH STUDY OF INTRAVENOUS RECCE327: A NOVEL, BROAD SPECTRUM, SYNTHETIC ANTI-INFECTIVE
Michele Dilizia
Favorite
DJEBLI, Nassim

Luzsana Biotechnonology (subsidiary of Jiangsu Hengrui Pharmaceuticals Co., Ltd)
PII-105 - COMBINED PARENT AND PAYLOAD POPULATION PHARMACOKINETIC MODELING TO SUPPORT DOSE RECOMMENDATION OF THE NOVEL ANTI-TROP-2 ANTIBODY-DRUG CONJUGATE (ADC) SHR-A1921.
Nassim DJEBLI
Favorite
PII-126 - MODEL-BASED META-ANALYSIS (MBMA) OF OBJECTIVE RESPONSE RATE (ORR) AND GRADE 3+ TREATMENT-RELATED ADVERSE EVENTS (G3TRAE) IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC).
Nassim DJEBLI
Favorite
PII-146 - POPULATION PHARMACOKINETIC MODELING OF CAMRELIZUMAB IN PATIENTS WITH VARIOUS CANCER TYPES, INCLUDING ADVANCED HEPATOCELLULAR CARCINOMA.
Nassim DJEBLI
Favorite
PII-148 - POPULATION PHARMACOKINETIC MODELING OF RIVOCERANIB IN HEALTHY SUBJECTS AND PATIENTS WITH VARIOUS CANCER TYPES, INCLUDING ADVANCED HEPATOCELLULAR CARCINOMA (HCC).
Nassim DJEBLI
Favorite
PII-149 - POPULATION PHARMACOKINETICS AND TUMOR GROWTH INHIBITION MODELING OF AN ANTI-CLAUDIN 18.2 ADC TO SUPPORT DRUG DEVELOPMENT DECISION-MAKING
Nassim DJEBLI
Favorite
PII-151 - POPULATION PHARMACOKINETICS OF REZVILUTAMIDE (SHR3680) WITH TIME-VARYING AND SATURABLE RELATIVE BIOAVAILABLITY IN PROSTATE CANCER PATIENTS
Nassim DJEBLI
Favorite
Dogterom, Peter

QPS Netherlands
PII-029 - PHARMACOKINETIC EVALUATION OF GB1211 IN A NOVEL TABLET FORMULATION, ADMINISTERED UNDER FASTED AND FED CONDITIONS, AND COMPARED TO GB1211 CAPSULES, IN HEALTHY VOLUNTEERS
Peter Dogterom
Favorite
PII-030 - PHASE 1 EVALUATION OF THE SAFETY, TOLERABILITY AND PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS OF THE ADENOSINE A1R/A3R AGONIST AST-004 AFTER INTRAVENOUS INFUSION IN HEALTHY VOLUNTEERS
Peter Dogterom
Favorite
Dong, Shuai

Sarepta Therapeutics, Inc.
PII-139 - PHARMACOMETRICS-BASED APPROACH TO FIRST-IN-HUMAN INTRAVENOUS DOSE DETERMINATION FOR SRP-6004 IN PATIENTS WITH LIMB GIRDLE MUSCULAR DYSTROPHY 2B
Shuai Dong
Favorite
Drabison, Thomas

The Ohio State University
PII-156 - STRAIN- AND ROUTE-DEPENDENT PLASMA PHARMACOKINETICS AND BRAIN PENETRATION OF PACLITAXEL.
Thomas Drabison
Favorite
Du, Ping

U.S. Food and Drug Administration
PII-171 - IDENTIFY BIOPREDICTIVE DISSOLUTION FOR PREDICTING IN VIVO PERFORMANCE OF A BCS II DRUG PRODUCT UNDER FED CONDITION
Ping Du
Favorite